- ►aei-brookings.org [PDF] JE Calfee - Journal of Public Policy & Marketing, 2002 - Am Marketing Assoc In August 1997, the Food and Drug Administration (FDA) announced a
reinterpretation of its rules on direct-to-consumer (DTC) advertising, the
effect of which was to permit branded broadcast advertisements and ... Cited by 99 - Related articles - BL Direct - All 18 versions
- ►healthaffairs.org SB Soumerai - Health Affairs, 2004 - Health Affairs States are reacting to increased Medicaid drug costs by implementing
cost-control policies, such as preferred drug lists (PDLs) and prior
authorization. PDLs have risks as well as benefits. Targeting essential ... Cited by 89 - Related articles - BL Direct - All 5 versions
- ►oxfordjournals.org M Fisch - JNCI Monographs, 2004 - jncimonographs.oupjournals.org Depression occurs in about 15% of the general population and is at least two to
three times more common in patients with cancer. Depression is often difficult
to diagnose in these patients because of the complexity and constraints of ... Cited by 52 - Related articles - BL Direct - All 10 versions
R Voellinger, A Berney, P Baumann, JM Annoni, … - General hospital psychiatry, 2003 - Elsevier Major Depressive Disorder is particularly frequent among physically ill
inpatients. Despite the considerable human burden and financial costs, Major
Depressive Disorder remains under-detected and under-treated. To improve ... Cited by 30 - Related articles - All 8 versions
- ►annals.org [PDF] JE Calfee - Annals of Internal Medicine, 2001 - Am Coll Physicians Price controls could have a substantial negative effect on pharma- ceutical
research and development. Extensive research is required before the development
costs of a new drug or its benefits are known; most new drug development ... Cited by 24 - Related articles - All 5 versions
- ►oxfordjournals.org DB Greenberg - JNCI Monographs, 2004 - jncimonographs.oupjournals.org Major depressive disorder is a relapsing syndrome with grave morbidity and
mortality. Much like asthma, it has a genetic predisposition and environmental
triggers. Specific antidepressant medications alone, tested in randomized, ... Cited by 22 - Related articles - BL Direct - All 9 versions
P Masand - Annals of Clinical Psychiatry (after Jan 1, 2004 - ingentaconnect.com Atypical antipsychotics have demonstrated beneficial effects on affective
symptoms, in addition to antipsychotic activity. Consequently, their role in the
treatment of bipolar disorder and treatment-resistant or psychotic ... Cited by 21 - Related articles - BL Direct - All 3 versions
- ►highwire.org NE Morden, LP Garrison Jr - Health Affairs, 2006 - healthaff.highwire.org Through the Part D drug program, Medicare has assumed responsibility for the
prescription drug needs of beneficiaries and, consequently, for an important
component of mental health treatment: psychotropic drugs. Managing the ... Cited by 14 - Related articles - All 8 versions
ID Glick - Primary Care Companion to The Journal of Clinical …, 2004 - pubmedcentral.nih.gov Recent studies have indicated that bipolar disorder is more common than
previously believed. The socioeconomic and personal burdens of this illness are
significant, and the lifetime risk of suicide attempts by patients with ... Cited by 10 - Related articles - All 3 versions
- ►stanford.edu [PDF] T Suppes, E Vieta, S Liu, M Brecher, B … - American Journal of Psychiatry, 2009 - Am Psychiatric Assoc OBJECTIVE: The authors evaluated the efficacy and safety of quetiapine plus
lithium or divalproex in the prevention of recurrent mood events in patients
with stabilized bipolar I disorder. METHOD: A total of 1,953 patients ... Cited by 8 - Related articles - All 4 versions
